{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-25-058893","form_type":"8-K","ticker":"BDTX","cik":"0001701541","company_name":"Black Diamond Therapeutics, Inc.","filed_at":"2025-06-12T23:59:59+00:00","discovered_at":"2026-05-14T18:02:49.389568+00:00","generated_at":"2026-05-19T10:48:54.862173+00:00","sec_items":["5.07"],"event_type":"other","sentiment":"neutral","materiality_score":0.25,"calibrated_materiality_score":0.15,"confidence":"high","headline":"Black Diamond Therapeutics elects three Class II directors, ratifies PwC","bullets":["Class II directors elected: Behbahani (14.5M for, 20.0M withheld), Menzel (33.5M for, 0.96M withheld), Kulkarni (14.2M for, 20.3M withheld); 8.5M broker non-votes each.","Ratification of PwC as auditor for FY2025 passed: 42.48M for, 0.45M against, 59k abstain.","Annual meeting held June 12, 2025 with 42.99M shares present out of 56.68M outstanding, establishing quorum."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-25-058893","json":"https://secwatch.observer/filing/0001104659-25-058893.json","markdown":"https://secwatch.observer/filing/0001104659-25-058893.md","text":"https://secwatch.observer/filing/0001104659-25-058893.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1701541/000110465925058893/0001104659-25-058893-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1701541/000110465925058893/tm2517877d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-19T10:48:54.862173+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}